Walsh, P.V., Bulbrook, R.D., Stell, P.M., Wang, D.Y., McDicken, I.W. and George, W.D. (1984) Serum Progesterone Concentration during the Luteal Phase in Women with Benign Breast Disease. European Journal of Cancer and Clinical Oncology, 20, 1339-1343.
http://dx.doi.org/10.1016/0277-5379(84)90051-8

has been cited by the following article:

• TITLE: The Influence of Progesterone Gel Therapy in the Treatment of Fibrocystic Breast Disease

  AUTHORS: Milena Brkic, Svetlana Vujovic, Maja Franic Ivanisevic, Miomira Ivovic, Milina Tancic Gajic, Ljiljana Marina, Marija Barac, Branko Barac, Alekasandar Djogo, Gabrijela Malesevic, Damir Franic

  KEYWORDS: Progesterone, Mastalgia, Mastodynia, Fibrocystic Breast Disease

  JOURNAL NAME: Open Journal of Obstetrics and Gynecology, Vol.6 No.5, April 28, 2016

  ABSTRACT: The effect of progesterone therapy on E2/P ratio changes during the luteal phase, and its consequences are on mastalgia and cyst, within a fibrocystic breast disease (FBD). Fifty women with FBD were included. Information for mastalgia and mastodynia were checked with a questionnaire. All women had (E2) and (P) concentration checked before and during the therapy on the 21st and 24th day of a cycle, ultrasound measured size and number of cysts before and during the therapy. T-test, X2-test, McNemar test, Wilcoxon test and Friedman test were used for statistics. There was a decrease E2/P relation during the therapy vs. before the treatment p